Precigen, Inc
PGEN
$7.74
-9.37%
Related headlines
PGEN price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Precigen, Inc's 12-month outlook, with a consensus price target around $13.65 and implied upside of +76.4% versus the current price.
Average Target
$13.65
0 analysts
Implied Upside
+76.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$11 - $18
Analyst target range
PGEN Technical Analysis
Beta
0.92
0.92x market volatility
Max Drawdown
-40.5%
Largest decline past year
52-Week Range
$3-$9
Price range past year
Annual Return
+138.2%
Cumulative gain past year
| Period | PGEN Return | S&P 500 |
|---|---|---|
| 1m | +9.0% | +0.6% |
| 3m | +40.5% | +3.6% |
| 6m | +87.9% | +14.6% |
| 1y | +138.2% | +15.8% |
| ytd | +80.8% | +13.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PGEN Fundamental Analysis
Quarterly Revenue
$54978000.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
94.9%
Latest Quarter
Free Cash Flow
$-115826000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PGEN Overvalued?
PE
-3.0x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-5.5x
Enterprise Value Multiple